DK1035220T3 - Oligonukleotidprimere til effektiv multiplekspåvisning af hepatitis C-virus (HCV) og human immunodefekt virus (HIV) samt fremgangsmåder til anvendelse deraf - Google Patents

Oligonukleotidprimere til effektiv multiplekspåvisning af hepatitis C-virus (HCV) og human immunodefekt virus (HIV) samt fremgangsmåder til anvendelse deraf

Info

Publication number
DK1035220T3
DK1035220T3 DK00300789T DK00300789T DK1035220T3 DK 1035220 T3 DK1035220 T3 DK 1035220T3 DK 00300789 T DK00300789 T DK 00300789T DK 00300789 T DK00300789 T DK 00300789T DK 1035220 T3 DK1035220 T3 DK 1035220T3
Authority
DK
Denmark
Prior art keywords
virus
hepatitis
methods
hcv
hiv
Prior art date
Application number
DK00300789T
Other languages
English (en)
Inventor
Kevin M Gorman
David R Patterson
Jeffrey M Linnen
Keming Song
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Application granted granted Critical
Publication of DK1035220T3 publication Critical patent/DK1035220T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • AIDS & HIV (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK00300789T 1999-02-03 2000-02-01 Oligonukleotidprimere til effektiv multiplekspåvisning af hepatitis C-virus (HCV) og human immunodefekt virus (HIV) samt fremgangsmåder til anvendelse deraf DK1035220T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11849899P 1999-02-03 1999-02-03

Publications (1)

Publication Number Publication Date
DK1035220T3 true DK1035220T3 (da) 2004-08-16

Family

ID=22378976

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00300789T DK1035220T3 (da) 1999-02-03 2000-02-01 Oligonukleotidprimere til effektiv multiplekspåvisning af hepatitis C-virus (HCV) og human immunodefekt virus (HIV) samt fremgangsmåder til anvendelse deraf

Country Status (13)

Country Link
US (1) US6623919B1 (da)
EP (1) EP1035220B1 (da)
JP (1) JP5442917B2 (da)
KR (1) KR100910545B1 (da)
CN (1) CN1213150C (da)
AT (1) ATE264925T1 (da)
AU (1) AU783171C (da)
CA (1) CA2296044C (da)
DE (1) DE60009977T2 (da)
DK (1) DK1035220T3 (da)
ES (1) ES2218067T3 (da)
NO (1) NO328535B1 (da)
PT (1) PT1035220E (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60041489D1 (de) * 1999-07-09 2009-03-19 Gen Probe Inc Nachweis von hiv-1 durch amplifizierung von nukleinsäuren
CA2318730C (en) * 1999-09-20 2008-01-22 Ortho-Clinical Diagnostics, Inc. A method for reverse transcribing rna isolated in dry form
ATE549421T1 (de) * 2003-12-19 2012-03-15 Gen Probe Inc Zusammensetzungen, verfahren und kits zum nachweis der nukleinsäuren von hiv-1 und hiv-2
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
EP2147118A4 (en) * 2007-04-27 2010-09-01 Eragen Biosciences Inc MATERIALS AND METHOD FOR DETECTING HEPATITIS C VIRUS
CN102171366B (zh) * 2008-07-31 2014-11-26 奥西泰克有限公司 多重扩增与检测
CN104120194B (zh) * 2014-08-08 2016-05-18 卫生部北京医院 一种病毒rna检测引物的设计方法及试剂盒
US10858711B2 (en) 2015-02-23 2020-12-08 University Of Washington Primers, probes and methods for sensitive, specific detection and monitoring of HIV-1 and HCV
CN106011309A (zh) * 2016-05-20 2016-10-12 凯杰生物工程（深圳）有限公司 用于检测人丙型肝炎病毒的引物组和探针
JP7203017B2 (ja) * 2016-09-07 2023-01-12 セイント ヴィンセンツ ホスピタル シドニー リミテッド レンチウイルスを検出する方法
US11021763B2 (en) 2017-10-03 2021-06-01 Abbott Molecular Inc. Assay for detecting hepatitis C virus (HCV)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5322770A (en) 1989-12-22 1994-06-21 Hoffman-Laroche Inc. Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription
US5856088A (en) * 1989-07-11 1999-01-05 Gen-Probe Incorporated Detection of human immunodeficiency virus type 1
US5491225A (en) * 1991-12-19 1996-02-13 Hoffmann-La Roche Inc. PCR primers for detection of legionella species and methods for controlling visual intensity in hybridization assays
US5747244A (en) 1991-12-23 1998-05-05 Chiron Corporation Nucleic acid probes immobilized on polystyrene surfaces
ATE179459T1 (de) * 1992-11-27 1999-05-15 Innogenetics Nv Verfahren zur typisierung von hcv-isolaten
IT1284847B1 (it) * 1996-06-07 1998-05-22 Sorin Biomedica Diagnostics Sp Procedimento per la rivelazione di acidi nucleici specifici di hcv
US6001558A (en) 1997-06-25 1999-12-14 Ortho Clinical Diagnostics, Inc. Amplification and detection of HIV-1 and/or HIV 2

Also Published As

Publication number Publication date
CN1213150C (zh) 2005-08-03
AU783171C (en) 2006-07-13
AU1482800A (en) 2000-08-03
DE60009977D1 (de) 2004-05-27
PT1035220E (pt) 2004-09-30
CN1268575A (zh) 2000-10-04
ES2218067T3 (es) 2004-11-16
NO328535B1 (no) 2010-03-15
ATE264925T1 (de) 2004-05-15
CA2296044A1 (en) 2000-08-03
DE60009977T2 (de) 2005-08-04
NO20000514L (no) 2000-08-04
NO20000514D0 (no) 2000-02-01
JP5442917B2 (ja) 2014-03-19
AU783171B2 (en) 2005-09-29
KR20000076598A (ko) 2000-12-26
US6623919B1 (en) 2003-09-23
JP2000279198A (ja) 2000-10-10
EP1035220A3 (en) 2001-08-22
CA2296044C (en) 2009-01-13
EP1035220A2 (en) 2000-09-13
EP1035220B1 (en) 2004-04-21
KR100910545B1 (ko) 2009-08-03

Similar Documents

Publication Publication Date Title
DK1026263T3 (da) Oligonukleotidprimere til omvendt transkription til effektiv detektering af HIV-1 og HIV-2 og fremgangsmåder til anvendelse deraf
DK1026262T3 (da) Oligonukleotidprimere til effektiv detektering af hepatitis C-virus (HCV) og fremgangsmåder til anvendelse deraf
DK0887427T3 (da) Amplifikation og detektion af HIV-1 og/eller HIV-2
DE69627408D1 (de) Primers und Sonden zum Nachweis von HIV
DK0776981T3 (da) Oligonucleotidprimere til amplifikation af HCV-nukleinsyre
DK1035220T3 (da) Oligonukleotidprimere til effektiv multiplekspåvisning af hepatitis C-virus (HCV) og human immunodefekt virus (HIV) samt fremgangsmåder til anvendelse deraf
DE69804464D1 (de) Nukleinsäuresequenzen als primer und sonden zur amplifizierung und erkennung von allen hiv-1 subtypen
DK0854197T3 (da) Primere til påvisning af HIV-1
ATE142276T1 (de) Nukleotid-sequenzen nützlich als typenspezifische sonden, pcr primers und lcr sonden zur amplifikation und zum nachweis von humanem papillomavirus, sowie dazu verwendete kits und verfahren
HK1053144A1 (en) Hepatitis b virus dna polymerase and surface antigen variants and methods of using same
IS5900A (is) Greining í tilraunaglasi (in vitro) á virkni DNA fjölliðuensíms lifrarbílgu B veiru í mönnum (HBV),og notkun hennar við skimun eftir hemlum DNA fjölliðuensíms HBV
NO20000537L (no) Oligonukleotidprimere for effektiv revers transkripsjon av hepatitt C virus (HCV) RNA og fremgangsmÕter for anvendelse derav
ZA200202506B (en) Method and device for the rapid clinical diagnosis of hepatitis B virus (HBV) infection in biological samples.
RU93013954A (ru) Способ обнаружения вируса иммунодефицита